Literature DB >> 29438040

Maternal and fetal risks of natalizumab exposure in utero: A fine balance.

Ruth Ann Marrie1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29438040     DOI: 10.1212/WNL.0000000000005075

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  1 in total

1.  Commentary on the ECTRIMS-EAN guideline for pharmacological treatment of multiple sclerosis.

Authors:  Alan J Thompson
Journal:  Ther Adv Neurol Disord       Date:  2018-04-17       Impact factor: 6.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.